Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial

MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, is pleased to provide an update on the company activities for the quarter ending 30 September 2023. Highlights: Partnership signed with the Gold Coast Private Hospital (a member of Healthscope), to establish a Precision Medicine Clinic at the hospital.GeneType Multi-Test

Related Keywords

Australia ,Melbourne ,Victoria ,Australian ,Richard Allman ,Jon Emery ,Simon Morriss ,Nicholas Murphy ,Adrian Mulcahy ,Erika Spaeth ,Chi Kuen Wong ,Genetic Technologies Limited ,Genomics Health Futures Mission Grant ,World Economic Forum ,Precision Medicine Pilot Partnership ,Genetic Technologies ,Centers For Medicare Medicaid ,National Association Of Testing Authority ,Research Future Fund ,Australian Institute Of Health ,Nasdaq ,Technologies Limited ,Gold Coast Private Hospital ,Precision Medicine Clinic ,Type Multi Test ,Pancreatic Cancer ,Atrial Fibrillation ,Chief Executive Officer Simon Morriss ,Achievements During ,Medicine Pilot Partnership ,Coast Private Hospital ,Type Multi Risk ,Precision Medicine Clinics ,Type Multi Risk Test ,National Association ,Testing Authority ,Breast Cancer ,Ovarian Cancer ,Prostate Cancer ,Colorectal Cancer ,Coronary Artery Disease ,Australian Institute ,Sole Industry Partner ,Medical Research Future Fund ,Genomics Health Futures Mission ,Professor Jon ,Australian Cancer Plan ,Reviewed Paper Publication ,Early Detection ,Gastro Hep ,Stakeholder Capitalism Metrics ,Wealthscope ,Mtg ,Risk Assessment ,Precision Medicine ,Dancer ,Partnership ,Private Hospital ,